skip to primary navigationskip to content
 

Drug Discovery and Development (3D) Workshop

This Pfizer 3D game enables all participants to collaborate throughout a computer simulated drug development process from pre-clinical research through to final product approval from the FDA.
When Jul 11, 2018
from 11:00 AM to 04:00 PM
Where Seminar Room B, First Floor 17 Mill Lane, Cambridge, CB2 1RX
Add event to calendar vCal
iCal

Attendance is free but strictly limited to 25 participants – please register with to reserve your place.

Participants work as an industrial project team, trying to get a great drug to patients. This workshop is a tailored version of a training system that is regularly provided to senior Pfizer R&D scientists and project team leaders.

The facilitator will guide the interactive session using a computer programme simulating the entire spectrum of R&D process based decisions (from target selection, in vivo & safety studies, IND filing, to clinical trial strategy and regulatory interactions).

During the game, your team will encounter decision points and then work together and engage in debate on how to move forward. These decisions will be influenced by data and test results produced by the simulation.

Your decisions and the related outcomes will affect overall quality and competitiveness of your program as reflected by R&D cost, patent/product life and time to market.

About the speaker: Nick leads Pfizer’s UK Academic interactions with the academic & medical institutions of the UK in identifying potential collaborations in the areas of biological space of interest to Pfizer’s Research Units.

This includes overseeing the formation of Innovative Target Exploration Networks (ITEN) of investigators to identify and validate targets including academic medical institutions such as the University of Cambridge.

Nick has a wide breadth of experience across the preclinical and clinical phase of drug discovery and development and in a variety of therapeutic areas including allergy, respiratory, inflammation and rare disease.

Nick has over 20 years’ pharmaceutical and 5 years’ academic experience and obtained his PhD in Anatomical Neuropharmacology at the University of Oxford in 1997 following his Bachelor’s degree in Pharmacology.

Who Should Participate: Researchers and academics who are interested in developing a deep appreciation of the decision processes, cost and timeline for new drug R&D; hands on experience in the drug R&D is preferred but not a must.

Register for the event: This workshop is free to attend and 25 places are available. Places will be filled on a first come-first served basis. Please email Dr Ruchi Chauhan from the Cambridge Academy of Therapeutic Sciences at ruchi.chauhan@admin.cam.ac.uk to reserve your place.

OPdA Tweets

RSS Feed Latest news

PPD Committee seeking new postdoc representative

May 20, 2019

The PPD Committee is seeking a new postdoc representative, to start from September 2019.

Join the Open Research Steering Committee

Mar 18, 2019

The Open Research Steering Committee are seeking two postdocs (one from STEMM and one from AHSS). Apply by 2 April 2019.

The Borysiewicz Fellows - Meet Team GC Connect

Feb 21, 2019

Meet Team GC Connect - they are on a mission to maximise the global impact of Cambridge research by creating opportunities for researchers to apply their expertise in the context of international development.

View all news